speb/financial-data huggingface dataset:
MOREPENLAB.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 0.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Net Income: 386752000.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 386752000.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 386755000.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 386752000.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 386752000.00
MOREPENLAB.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 557553000.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 386755000.00
MOREPENLAB.NS cash_flow (annual, 2023-03-31) — Net Intangibles Purchase And Sale: -103514000.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Net Interest Income: -3234000.00
MOREPENLAB.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 0.00
MOREPENLAB.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 65951000.00
MOREPENLAB.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -3876000.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -3234000.00
MOREPENLAB.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: 17768000.00
MOREPENLAB.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -5373000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Net PPE: 2476542000.00
MOREPENLAB.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -356206000.00
MOREPENLAB.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 69827000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 6526747000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 26860000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 297446000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 63933000.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 856665000.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Normalized Income: 386752000.00
MOREPENLAB.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: -911706000.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Operating Income: 516025000.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Operating Revenue: 14139548000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 511168708.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 2019395000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 5782000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 6506810000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 257592000.00
MOREPENLAB.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 19808000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 639177000.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 44760000.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 919589000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Other Payable: 221456000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Other Properties: 1669990000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 28763000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 401524000.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Payables: 2506707000.00
MOREPENLAB.NS cash_flow (annual, 2023-03-31) — Pension And Employee Benefit Expense: -20062000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 2048496000.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Pretax Income: 557553000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
MOREPENLAB.NS cash_flow (annual, 2023-03-31) — Purchase Of Intangibles: -103514000.00
MOREPENLAB.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -356206000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 1311119000.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 9703728000.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 279304000.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 107401000.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 107401000.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Research And Development: 30689000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 346397000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 1900120000.00
MOREPENLAB.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 0.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 930136000.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 1071758000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Share Issued: 511168708.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 7529081000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 6526747000.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Tax Provision: 170798000.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.31
MOREPENLAB.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -165539000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Total Assets: 11104951000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 7538416000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Total Debt: 251641000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 7524477000.00
MOREPENLAB.NS income_statement (annual, 2023-03-31) — Total Expenses: 13623523000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 3580474000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 3543304000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 368843000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 16458000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Trading Securities: 0.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Work In Process: 386455000.00
MOREPENLAB.NS balance_sheet (annual, 2023-03-31) — Working Capital: 4350016000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — +Operating Expense: 4734563000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — +Total Revenue: 16821343000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 2950275000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 3249381000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -2614021000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 4460219000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -29362000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 157810000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 13010000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 511168708.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Basic EPS: 1.88
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 216658000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 996076000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -813355000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 0.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 1022271000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 169451000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 169451000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 169451000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -197079000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 794768000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -1178921000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -581232000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -47207000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Common Stock: 1022271000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 8472262000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 0.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 880934000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 10835229000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Current Assets: 8890440000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 0.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Current Debt: 256352000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 256352000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 4020446000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 250150000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Depreciation: 176885000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 334695000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 334695000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 334695000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 511168708.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Diluted EPS: 1.88
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 961599000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — EBIT: 1391259000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — EBITDA: 1725954000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — End Cash Position: 169451000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 52049000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 625497000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: -79609000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 0.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 173357000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Goodwill: 744742000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 943700000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 3278743000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 5626996000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Gross Profit: 5986114000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Interest Expense: 37102000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 37102000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Interest Income: 25041000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 25041000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -37102000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Inventory: 2485942000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 8762254000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -833002000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 13010000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 0.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 38351000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 14328000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 0.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 33640000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 33640000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 24305000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 338166000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 3735658000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 0.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Minority Interests: -4604000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 0.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Net Debt: 120541000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: 2305000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Net Income: 961599000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 961599000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 966203000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 961599000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 961599000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 1354157000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 966203000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Net Intangibles Purchase And Sale: -99547000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Net Interest Income: -12061000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -13010000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 38351000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 24305000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -12061000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: 50800000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: -7169000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Net PPE: 3012975000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -713276000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 14046000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 7528562000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 22495000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 71567000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 1725954000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Normalized Income: 961599000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 733746000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Operating Income: 1251551000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Operating Revenue: 16821343000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 511168708.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: -3000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 5782000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 7449991000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 198958000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 37102000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 638844000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 17699000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 1222254000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Other Payable: 197001000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Other Properties: 2132041000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 65757000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 495530000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Payables: 3184696000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Pension And Employee Benefit Expense: -27524000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 2568197000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Pretax Income: 1354157000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Purchase Of Intangibles: -99547000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -13010000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -713808000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 1486308000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 10835229000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 334695000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 120812000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 120812000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Research And Development: 51983000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 351715000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 2861719000.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 532000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 1099789000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 1273146000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Share Issued: 511168708.00
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Short Term Debt Issuance: 14046000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 8472262000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 7528562000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Tax Provision: 387954000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.29
MOREPENLAB.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -381153000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Total Assets: 12932051000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 8505902000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Total Debt: 289992000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 8472262000.00
MOREPENLAB.NS income_statement (annual, 2024-03-31) — Total Expenses: 15569792000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 4459789000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 4041611000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 439343000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 37420000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Trading Securities: 13010000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Work In Process: 374137000.00
MOREPENLAB.NS balance_sheet (annual, 2024-03-31) — Working Capital: 4869994000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 2946321000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 3002007000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 82294000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 1095841000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 195454000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 2042152000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 1095841000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 11104338000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 184944000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 10929800000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 297600000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 297600000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 4064992000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 305094000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Goodwill: 744743000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 1037486000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 2698255000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 2823884000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 11439284000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 82294000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 37346000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 37346000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 348309000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 139492000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 2698255000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 10066852000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 22495000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 547953699.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 3059514000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 56888000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 10008497000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 292743000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 874342000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 2513311000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Receivables: 2243000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 1846698000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Payables: 2946321000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 547953699.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 11104338000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 10066852000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 15622536000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 11141684000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 334946000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 11104338000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 4518198000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 4692736000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 453206000.00
MOREPENLAB.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 6864808000.00
MOREPENLAB.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
MOREPENLAB.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
MOREPENLAB.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — +Operating Expense: 5071800000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 1243262000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — +Total Revenue: 18115758000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 4658533000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 3633031000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 3633031000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 3247634000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 3247634000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -2875808000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -2875808000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 6293953000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 6293953000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -36892000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -36892000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 4977000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 71742000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 71742000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 536456364.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 580440000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Basic EPS: 2.20
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 0.35
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 169451000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 1122608000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -2142366000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 257025000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 257025000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 1095841000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1095841000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 273812000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 273812000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1384236000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1051880000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 273812000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 273812000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -513708000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 583911000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -1307140000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -1236937000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 104361000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Common Stock: 1095841000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 1095841000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: 0.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 11562307000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 11562307000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 1907304000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 1149022000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 1149022000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 11593072000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 3157522000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Current Assets: 11593717000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 11593717000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 122184000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 122184000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Current Debt: 536346000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 536346000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 658530000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 658530000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 5006536000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 5006536000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 195980000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 195980000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Depreciation: 289817000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 289817000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 289817000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 164679000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 289817000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 164679000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 536456364.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 580440000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Diluted EPS: 2.20
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.35
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 1180204000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 203154000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — EBIT: 1634523000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — EBIT: 303863000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — EBITDA: 1924340000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — EBITDA: 468542000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — End Cash Position: 273812000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 2998860000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 799909000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 799909000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -1821799000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of Business: 0.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 1517000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 222024000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Goodwill: 744742000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 744742000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 1467116000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1467116000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 3284526000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 3284526000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 7444764000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 7444764000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Gross Profit: 6522686000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 1501011000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Interest Expense: 83429000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 46716000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 83429000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 46716000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Interest Income: 48151000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 48151000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -83429000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Inventory: 2999650000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 2999650000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 12356234000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 12356234000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -3215066000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 71742000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 71742000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 1907304000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 311836000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 232688000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 232688000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 134841000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 134841000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 257581000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 257581000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 392422000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 392422000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 311836000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -33350000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 398476000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 398476000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 4567613000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 4567613000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 307268000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 307268000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Minority Interests: 50000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 50000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: 0.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 1907304000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Net Debt: 520115000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 520115000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 612000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Net Income: 1180204000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Net Income: 203154000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 1180204000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 203154000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 1180154000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 203104000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 1180204000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 203154000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 1180204000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 203154000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 1551094000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 1180154000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 203104000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Net Intangibles Purchase And Sale: -902035000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Net Interest Income: -83429000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -46716000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -836799000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 503935000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 278486000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -83429000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -46716000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: 414025000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -236407000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Net PPE: 4568956000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 4568956000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -1239825000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 225449000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 10095191000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 10095191000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 69766000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 69766000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 78030000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 78030000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 1924340000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 468542000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Normalized Income: 1180204000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 203154000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 320567000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Operating Income: 1450886000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Operating Income: 257749000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Operating Revenue: 18115758000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 4658533000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 547953699.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 547953699.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 3957401000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 3957401000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 18134000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 18134000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 10466466000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 10466466000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 722374000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 722374000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 83429000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 867891000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 867891000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 183637000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 46114000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 1892981000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 459646000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Other Payable: 107036000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 107036000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Other Properties: 372833000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 372833000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 28023000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 28023000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 778068000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 778068000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Payables: 3770561000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Payables: 3770561000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Pension And Employee Benefit Expense: 2505000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 4046737000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 4046737000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Pretax Income: 1551094000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 257147000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Purchase Of Intangibles: -902035000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -836799000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -1240331000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 1613546000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 11593072000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 3157522000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 289817000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 164679000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 29333000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -33350000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Research And Development: 36937000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 219793000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 219793000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 4041923000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 4041923000.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Sale Of Business: 0.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 506000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 799863000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 48864000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 799863000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 48864000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Share Issued: 547953699.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 547953699.00
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Short Term Debt Issuance: 279994000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 11562307000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 11562307000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 10095191000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 10095191000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Tax Provision: 370940000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 54043000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.24
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
MOREPENLAB.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -371520000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Total Assets: 17780993000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 17780993000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 11819888000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 11819888000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Total Debt: 1050952000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 1050952000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 11869575000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 11869575000.00
MOREPENLAB.NS income_statement (annual, 2025-03-31) — Total Expenses: 16664872000.00
MOREPENLAB.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 4400784000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 5911418000.00
MOREPENLAB.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 5911418000.00
MOREPENLAB.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 6187276000.00